Literature DB >> 26836327

Duality at the gate: Skin dendritic cells as mediators of vaccine immunity and tolerance.

Christopher J Nirschl1, Niroshana Anandasabapathy1.   

Abstract

Since Edward Jenner's discovery that intentional exposure to cowpox could provide lifelong protection from smallpox, vaccinations have been a major focus of medical research. However, while the protective benefits of many vaccines have been successfully translated into the clinic, the cellular and molecular mechanisms that differentiate effective vaccines from sub-optimal ones are not well understood. Dendritic cells (DCs) are the gatekeepers of the immune system, and are ultimately responsible for the generation of adaptive immunity and lifelong protective memory through interactions with T cells. In addition to lymph node and spleen resident DCs, a number of tissue resident DC populations have been identified at barrier tissues, such as the skin, which migrate to the local lymph node (migDC). These populations have unique characteristics, and play a key role in the function of cutaneous vaccinations by shuttling antigen from the vaccination site to the draining lymph node, rapidly capturing freely draining antigens in the lymph node, and providing key stimuli to T cells. However, while migDCs are responsible for the generation of immunity following exposure to certain pathogens and vaccines, recent work has identified a tolerogenic role for migDCs in the steady state as well as during protein immunization. Here, we examine the roles and functions of skin DC populations in the generation of protective immunity, as well as their role as regulators of the immune system.

Entities:  

Keywords:  DC targeted vaccines; dendritic cells; immune tolerance; migratory DCs

Mesh:

Substances:

Year:  2016        PMID: 26836327      PMCID: PMC4962728          DOI: 10.1080/21645515.2015.1066050

Source DB:  PubMed          Journal:  Hum Vaccin Immunother        ISSN: 2164-5515            Impact factor:   3.452


  141 in total

1.  The adaptor protein FADD protects epidermal keratinocytes from necroptosis in vivo and prevents skin inflammation.

Authors:  Marion C Bonnet; Daniela Preukschat; Patrick-Simon Welz; Geert van Loo; Maria A Ermolaeva; Wilhelm Bloch; Ingo Haase; Manolis Pasparakis
Journal:  Immunity       Date:  2011-10-13       Impact factor: 31.745

2.  Behavioral responses of epidermal Langerhans cells in situ to local pathological stimuli.

Authors:  Akiko Nishibu; Brant R Ward; James V Jester; Hidde L Ploegh; Marianne Boes; Akira Takashima
Journal:  J Invest Dermatol       Date:  2006-04       Impact factor: 8.551

3.  Normal proportion and expression of maturation markers in migratory dendritic cells in the absence of germs or Toll-like receptor signaling.

Authors:  Nicholas S Wilson; Louise J Young; Fiona Kupresanin; Shalin H Naik; David Vremec; William R Heath; Shizuo Akira; Ken Shortman; Jeff Boyle; Eugene Maraskovsky; Gabrielle T Belz; José A Villadangos
Journal:  Immunol Cell Biol       Date:  2007-11-20       Impact factor: 5.126

4.  Skin-derived dendritic cells can mediate deletional tolerance of class I-restricted self-reactive T cells.

Authors:  Jason Waithman; Rhys S Allan; Hiroshi Kosaka; Hiroaki Azukizawa; Ken Shortman; Manfred B Lutz; William R Heath; Francis R Carbone; Gabrielle T Belz
Journal:  J Immunol       Date:  2007-10-01       Impact factor: 5.422

5.  Dendritic cell targeting of survivin protein in a xenogeneic form elicits strong CD4+ T cell immunity to mouse survivin.

Authors:  Anna Charalambous; Margarita Oks; Godwin Nchinda; Sayuri Yamazaki; Ralph M Steinman
Journal:  J Immunol       Date:  2006-12-15       Impact factor: 5.422

6.  Predictive correlates of response to the anti-PD-L1 antibody MPDL3280A in cancer patients.

Authors:  Roy S Herbst; Jean-Charles Soria; Marcin Kowanetz; Gregg D Fine; Omid Hamid; Michael S Gordon; Jeffery A Sosman; David F McDermott; John D Powderly; Scott N Gettinger; Holbrook E K Kohrt; Leora Horn; Donald P Lawrence; Sandra Rost; Maya Leabman; Yuanyuan Xiao; Ahmad Mokatrin; Hartmut Koeppen; Priti S Hegde; Ira Mellman; Daniel S Chen; F Stephen Hodi
Journal:  Nature       Date:  2014-11-27       Impact factor: 49.962

Review 7.  Plasmacytoid dendritic cells: recent progress and open questions.

Authors:  Boris Reizis; Anna Bunin; Hiyaa S Ghosh; Kanako L Lewis; Vanja Sisirak
Journal:  Annu Rev Immunol       Date:  2011       Impact factor: 28.527

8.  Evidence that the bulge region is a site of relative immune privilege in human hair follicles.

Authors:  K C Meyer; J E Klatte; H V Dinh; M J Harries; K Reithmayer; W Meyer; R Sinclair; R Paus
Journal:  Br J Dermatol       Date:  2008-09-15       Impact factor: 9.302

9.  Expression of the zinc finger transcription factor zDC (Zbtb46, Btbd4) defines the classical dendritic cell lineage.

Authors:  Matthew M Meredith; Kang Liu; Guillaume Darrasse-Jeze; Alice O Kamphorst; Heidi A Schreiber; Pierre Guermonprez; Juliana Idoyaga; Cheolho Cheong; Kai-Hui Yao; Rachel E Niec; Michel C Nussenzweig
Journal:  J Exp Med       Date:  2012-05-21       Impact factor: 14.307

10.  Langerin+ dermal DC, but not Langerhans cells, are required for effective CD8-mediated immune responses after skin scarification with vaccinia virus.

Authors:  Julien Seneschal; Xiaodong Jiang; Thomas S Kupper
Journal:  J Invest Dermatol       Date:  2013-10-14       Impact factor: 8.551

View more
  6 in total

1.  Near-Infrared 1064 nm Laser Modulates Migratory Dendritic Cells To Augment the Immune Response to Intradermal Influenza Vaccine.

Authors:  Kaitlyn Morse; Yoshifumi Kimizuka; Megan P K Chan; Mai Shibata; Yusuke Shimaoka; Shu Takeuchi; Benjamin Forbes; Christopher Nirschl; Binghao Li; Yang Zeng; Roderick T Bronson; Wataru Katagiri; Ayako Shigeta; Ruxandra F Sîrbulescu; Huabiao Chen; Rhea Y Y Tan; Kosuke Tsukada; Timothy Brauns; Jeffrey Gelfand; Ann Sluder; Joseph J Locascio; Mark C Poznansky; Niroshana Anandasabapathy; Satoshi Kashiwagi
Journal:  J Immunol       Date:  2017-07-14       Impact factor: 5.422

Review 2.  The origin of DCs and capacity for immunologic tolerance in central and peripheral tissues.

Authors:  K Sanjana P Devi; Niroshana Anandasabapathy
Journal:  Semin Immunopathol       Date:  2016-11-25       Impact factor: 9.623

3.  Laser adjuvant for vaccination.

Authors:  Satoshi Kashiwagi
Journal:  FASEB J       Date:  2020-01-28       Impact factor: 5.191

Review 4.  To the Skin and Beyond: The Immune Response to African Trypanosomes as They Enter and Exit the Vertebrate Host.

Authors:  Omar A Alfituri; Juan F Quintana; Annette MacLeod; Paul Garside; Robert A Benson; James M Brewer; Neil A Mabbott; Liam J Morrison; Paul Capewell
Journal:  Front Immunol       Date:  2020-06-12       Impact factor: 7.561

Review 5.  Tolerogenic Dendritic Cells as a Promising Antigen-Specific Therapy in the Treatment of Multiple Sclerosis and Neuromyelitis Optica From Preclinical to Clinical Trials.

Authors:  Georgina Flórez-Grau; Irati Zubizarreta; Raquel Cabezón; Pablo Villoslada; Daniel Benitez-Ribas
Journal:  Front Immunol       Date:  2018-05-31       Impact factor: 7.561

Review 6.  Unleashing the immune response to NY-ESO-1 cancer testis antigen as a potential target for cancer immunotherapy.

Authors:  Afsheen Raza; Maysaloun Merhi; Varghese Philipose Inchakalody; Roopesh Krishnankutty; Allan Relecom; Shahab Uddin; Said Dermime
Journal:  J Transl Med       Date:  2020-03-27       Impact factor: 5.531

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.